65 related articles for article (PubMed ID: 28692418)
21. Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden.
Bart G; Heilig M; LaForge KS; Pollak L; Leal SM; Ott J; Kreek MJ
Mol Psychiatry; 2004 Jun; 9(6):547-9. PubMed ID: 15037869
[No Abstract] [Full Text] [Related]
22. Ligand-specific pharmacogenetic effects of nonsynonymous mutations.
Morningstar-Kywi N; Haworth IS; Mosley SA
Pharmacogenet Genomics; 2021 Jun; 31(4):75-82. PubMed ID: 33395026
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of prodynorphin gene polymorphisms and their association with heroin addiction in a sample of the southeast Iranian population.
Hashemi M; Shakiba M; Sanaei S; Shahkar G; Rezaei M; Mojahed A; Bahari G
Mol Biol Res Commun; 2018 Mar; 7(1):1-6. PubMed ID: 29911117
[TBL] [Abstract][Full Text] [Related]
24. Associated and intermediate factors between genetic variants of the dopaminergic D2 receptor gene and harmful alcohol use in young adults.
Mattioni J; Vansteene C; Poupon D; Gorwood P; Ramoz N
Addict Biol; 2023 Mar; 28(3):e13269. PubMed ID: 36825486
[TBL] [Abstract][Full Text] [Related]
25. OPRD1 SNPs associated with opioid addiction are cis-eQTLs for the phosphatase and actin regulator 4 gene, PHACTR4, a mediator of cytoskeletal dynamics.
Levran O; Randesi M; Adelson M; Kreek MJ
Transl Psychiatry; 2021 May; 11(1):316. PubMed ID: 34031368
[TBL] [Abstract][Full Text] [Related]
26. AddictGene: An integrated knowledge base for differentially expressed genes associated with addictive substance.
Shi L; Wang Y; Li C; Zhang K; Du Q; Zhao M
Comput Struct Biotechnol J; 2021; 19():2416-2422. PubMed ID: 34025933
[TBL] [Abstract][Full Text] [Related]
27. Identification of a sex-stratified genetic algorithm for opioid addiction risk.
Bright D; Langerveld A; DeVuyst-Miller S; Saadeh C; Choker A; Lehigh E; Wheeler S; Zayzafoon A; Sohn M
Pharmacogenomics J; 2021 Jun; 21(3):326-335. PubMed ID: 33589790
[TBL] [Abstract][Full Text] [Related]
28. Expression of Dopamine-Related Genes in Four Human Brain Regions.
Stanfill AG; Cao X
Brain Sci; 2020 Aug; 10(8):. PubMed ID: 32824878
[TBL] [Abstract][Full Text] [Related]
29. The opioid crisis: a contextual, social-ecological framework.
Jalali MS; Botticelli M; Hwang RC; Koh HK; McHugh RK
Health Res Policy Syst; 2020 Aug; 18(1):87. PubMed ID: 32762700
[TBL] [Abstract][Full Text] [Related]
30. Dopamine Receptor DRD2 Gene rs1076560, Personality Traits and Anxiety in the Polysubstance Use Disorder.
Suchanecka A; Chmielowiec J; Chmielowiec K; Masiak J; Sipak-Szmigiel O; Sznabowicz M; Czarny W; Michałowska-Sawczyn M; Trybek G; Grzywacz A
Brain Sci; 2020 Apr; 10(5):. PubMed ID: 32365807
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphisms in the opioid receptor delta 1 (OPRD1) gene are associated with methadone dose in methadone maintenance treatment for heroin dependence.
Fang CP; Wang SC; Tsou HH; Chung RH; Hsu YT; Liu SC; Kuo HW; Liu TH; Chen ACH; Liu YL
J Hum Genet; 2020 Apr; 65(4):381-386. PubMed ID: 31907389
[TBL] [Abstract][Full Text] [Related]
32. Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders.
Burns JA; Kroll DS; Feldman DE; Kure Liu C; Manza P; Wiers CE; Volkow ND; Wang GJ
Front Psychiatry; 2019; 10():626. PubMed ID: 31620026
[TBL] [Abstract][Full Text] [Related]
33. Four single nucleotide polymorphisms in genes involved in neuronal signaling are associated with Opioid Use Disorder in West Virginia.
Kaski SW; Brooks S; Wen S; Haut MW; Siderovski DP; Berry JH; Lander LR; Setola V
J Opioid Manag; 2019; 15(2):103-109. PubMed ID: 31057342
[TBL] [Abstract][Full Text] [Related]
34. Association of OPRD1 polymorphisms with heroin dependence in a large case-control series.
Nelson EC; Lynskey MT; Heath AC; Wray N; Agrawal A; Shand FL; Henders AK; Wallace L; Todorov AA; Schrage AJ; Madden PA; Degenhardt L; Martin NG; Montgomery GW
Addict Biol; 2014 Jan; 19(1):111-21. PubMed ID: 22500942
[TBL] [Abstract][Full Text] [Related]
35. Association between dopamine D2 receptor gene polymorphisms and the risk of heroin dependence.
Wang N; Zhang JB; Zhao J; Cai XT; Zhu YS; Li SB
Genet Mol Res; 2016 Nov; 15(4):. PubMed ID: 27819741
[TBL] [Abstract][Full Text] [Related]
36. Genetic susceptibility to heroin addiction: a candidate gene association study.
Levran O; Londono D; O'Hara K; Nielsen DA; Peles E; Rotrosen J; Casadonte P; Linzy S; Randesi M; Ott J; Adelson M; Kreek MJ
Genes Brain Behav; 2008 Oct; 7(7):720-9. PubMed ID: 18518925
[TBL] [Abstract][Full Text] [Related]
37. OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis.
Haerian BS; Haerian MS
Pharmacogenomics; 2013 May; 14(7):813-24. PubMed ID: 23651028
[TBL] [Abstract][Full Text] [Related]
38. A review of opioid addiction genetics.
Crist RC; Reiner BC; Berrettini WH
Curr Opin Psychol; 2019 Jun; 27():31-35. PubMed ID: 30118972
[TBL] [Abstract][Full Text] [Related]
39. Contribution of Genetic Polymorphisms and Haplotypes in DRD2, BDNF, and Opioid Receptors to Heroin Dependence and Endophenotypes Among the Han Chinese.
Gao X; Wang Y; Lang M; Yuan L; Reece AS; Wang W
OMICS; 2017 Jul; 21(7):404-412. PubMed ID: 28692418
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
